Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Food insecurity, defined as difficulty accessing food owing to cost, affects 1 in 5 diabetes patients. To address this, the investigators are conducting a pilot randomized controlled trial of medically tailored meal delivery (MTM). The pilot study has two specific aims:
Aim 1: To determine the effect of receiving MTM on dietary quality for food insecure diabetes patients with hyperglycemia Aim 2: To determine the feasibility and acceptability of the program as a medical intervention and refine the program as needed for testing in larger studies.
This study is a crossover randomized controlled pilot trial, where approximately 50 participants, 25 in each arm, will be randomized to receipt of 12 weeks of MTM, to begin immediately, or waitlist control. After 12 weeks, the groups will crossover, with the waitlist control group now receiving 12 weeks of MTM. At baseline, 12 weeks, and 24 weeks, the participants will complete assessments of their dietary quality (HEI score), psychosocial measures such as diabetes distress and food insecurity, along with measures of body mass index, blood pressure, hemoglobin A1c, and lipids.
a. Historical background The Center for Disease Control and Prevention (CDC) estimates that there are currently 29 million people with diabetes and 86 million people with pre-diabetes in the U.S. One in 10 Americans has diabetes now, and, if current trends continue, 1 in 3 Americans will have diabetes by 2050. This chronic disease significantly impacts both quality of life and rapidly rising national healthcare costs. The estimated cost of diabetes in the U.S. in 2014 was $265 billion with $176 billion in direct medical costs and $89 billion is indirect medical costs (disability, work loss, premature mortality). Medical expenses for people with diabetes are 2.3 times higher than for people without diabetes.
Food insecurity, defined as limited access to nutritious food due to cost, has been associated with increased prevalence of diabetes and worse diabetes control. Food insecurity may worsen diabetes by decreasing consumption of fresh fruits and vegetables and increasing consumption of inexpensive, calorie-dense food, and which in turn leads to greater Hemoglobin A1c, an indicator of hyperglycemia, over time.
c. Rationale behind the proposed research, and potential benefits to participants and/or society
Approximately 20% of diabetes patients report food insecurity, a number that increases to over 25% among those with the worst metabolic control.5 The prevalence of food insecurity is also 20% in the MGH Population we surveyed (data not yet published). Hyperglycemia is particularly responsive to dietary changes,8 yet few interventions have attempted to address food insecurity in diabetes care. Prior studies have examined the impact of the Supplemental Nutrition Assistance Program (SNAP, formerly the Food Stamp Program), but have not found important improvements in diabetes outcomes for participants9. This may be because neighborhood access to produce and other high quality food is low for many SNAP participants, or because making healthy food choices is difficult in resource-constrained environments. Additionally, recent sociological work has shown that expecting low-income women to cook healthy meals for their families induces a significant burden, and the burden of these expectations may drive less healthy food choices. Additionally, while significant time is needed for healthy food preparation, low-income patients often face limited leisure time, and multiple competing demands for both time and financial resources. Alternatively, direct provision of healthy foods was incidentally noted to improve diabetes outcomes in a prior randomized controlled trial, but this study was not conducted with the goal of addressing food insecurity.
In this study, we propose to test whether home delivery of freshly prepared meals specifically tailored to the needs of diabetes patients improves their dietary quality. We hypothesize that the delivery of the meals will help them eat more healthily and improve the food security of participants. Secondary outcomes in this pilot study will be weight and metabolic control, along with psychological aspects of diabetes care.
Aim 1: To evaluate the effectiveness of receiving Community Servings meals on dietary quality for food insecure diabetes patients with severe hyperglycemia (HbA1c > 8.0%) H1. Primary outcome. Healthy Eating Index 2010 (HEI) score: We hypothesize that the CS group will demonstrate greater improvements in dietary quality, as assessed by HEI score, at 12 weeks, compared with usual care. The sample size of 50 provides 80% power to detect a 5 point difference between the CS and usual care groups, assuming an 11 point standard deviation and accounting for a 10% drop-out rate.
H1b. Secondary exploratory outcomes. Medical outcomes: We hypothesize that compared with usual care, CS group participants will improve HbA1c, blood pressure, weight, and lipids from baseline at the end of the intervention.
H1c. Behavioral and psychosocial outcomes: Because meal provision will reduce stress related to procuring healthy meals, and free up household resources that would otherwise be spent on food, we hypothesize that compared with usual care, the CS groups will have greater improvements from baseline in patient-reported outcomes of diabetes distress and material need security.
Aim 2: To evaluate the feasibility of providing meals and patient experience with the CS program, particularly focusing on factors that determine acceptability, continuation, and scalability We will use a mixed methods approach using participant structured interviews and surveys to assess engagement and satisfaction with the program, and participant interviews or focus groups to compare responders and non-responders. We will also collect quantitative indicators of feasibility and implementation such as percent of meals delivered and consumed, enrollment and persistence with the program, and logistical issues in order to plan for a future full-scale intervention.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Med. Tailored Meal Delivery, Usual Care + Choose Myplate | Experimental | Participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure for 12 weeks. |
|
| Usual Care + Choose Myplate, Med. Tailored Meal Delivery | Active Comparator | Participants will receive usual diabetes care and a Choose MyPlate healthy eating brochure for 12 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Medically Tailored Meal Delivery (MTM) | Other | Patients will receive delivery of medically tailored meals for 12 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Healthy Eating Index 2010 Score | Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected | Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Food Insecurity | Food insecurity is defined as > 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Diabetes Distress Scale |
| Measure | Description | Time Frame |
|---|---|---|
| Hemoglobin A1c | This will be measured using a fasting blood draw at baseline, 12 and 24 weeks | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| LDL Cholesterol | A fasting blood draw will be used to measure: LDL Cholesterol |
Inclusion Criteria:
• Diagnosis of type 2 diabetes
Exclusion Criteria:
• Must not be pregnant or planning pregnancy in the next year
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Seth A Berkowitz, MD MPH | Massachusetts General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30421335 | Result | Berkowitz SA, Delahanty LM, Terranova J, Steiner B, Ruazol MP, Singh R, Shahid NN, Wexler DJ. Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: a Randomized Cross-over Trial. J Gen Intern Med. 2019 Mar;34(3):396-404. doi: 10.1007/s11606-018-4716-z. Epub 2018 Nov 12. | |
| 31959176 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Meal Delivery Then Usual Care + Choose myPlate | During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm. Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm. |
| FG001 | Usual Care + Choose myPlate Then Meal Delivery | During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm. Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Intervention (12 Weeks) |
|
| ||||||||||||||||||
| Second Intervention (12 Weeks) |
| |||||||||||||||||||
| Intent to Treat Population Milestone |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Meal Delivery Then Usual Care + Choose myPlate | During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm. Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Healthy Eating Index 2010 Score | Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected | ITT | Posted | Mean | Standard Deviation | units on a scale | Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study) |
|
24 weeks
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Medically Tailored Meal Delivery | Participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Medically Tailored Meal Delivery (MTM): Patients will receive delivery of medically tailored meals for 12 weeks Usual Care + Choose MyPlate: Patients will receive usual diabetes care + a Choose MyPlate healthy eating brochure |
Not provided
Not provided
Short-term study designed to test change in diet quality only. Not designed for clinical endpoints Single center study in one region of US
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Seth A. Berkowitz | University of North Carolina at Chapel Hill | 919-966-2276 | seth__berkowitz@med.unc.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Apr 19, 2015 | Apr 14, 2019 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Usual Care + Choose MyPlate | Other | Patients will receive usual diabetes care + a Choose MyPlate healthy eating brochure for 12 weeks |
|
Diabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better |
| Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Body Mass Index | Body Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale. Height measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness. | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Systolic Blood Pressure | Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest. | Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer |
| Diastolic Blood Pressure | Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest. | Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer |
| Change From Baseline in Medication Adherence | Change from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Number of Participants With Cost Related Medication Under-Use | Cost Related Medication Under-use (Defined as > 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey) | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Number of Participants With Food and Medication Trade-offs | Prevalence of food and medication trade-offs between groups | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Depressive Symptoms (Assessed Using the PHQ-8 Scale) | Patient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Change From Baseline in Cognitive Burden (Assessed Using Times on the Stroop Task) | This outcome was planned to be measured but not measured owing to technical difficulties in assessment | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Number of Participants With Self-reported Hypoglycemia | Report of hypoglycemia requiring assistance in last 3 months | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
| Triglycerides | A fasting blood draw will be used to measure: Triglycerides | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
| HDL Cholesterol | A fasting blood draw will be used to measure: HDL Cholesterol | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
| Total Cholesterol | A fasting blood draw will be used to measure: Total Cholesterol | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
| Berkowitz SA, Shahid NN, Terranova J, Steiner B, Ruazol MP, Singh R, Delahanty LM, Wexler DJ. "I was able to eat what I am supposed to eat"-- patient reflections on a medically-tailored meal intervention: a qualitative analysis. BMC Endocr Disord. 2020 Jan 20;20(1):10. doi: 10.1186/s12902-020-0491-z. |
| NOT COMPLETED |
|
| NOT COMPLETED |
|
| BG001 | Usual Care + Choose myPlate Then Meal Delivery | During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm. Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Healthy Eating Index 2010 Score | Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality | Mean | Standard Deviation | units on a scale |
|
|
|
| Secondary | Number of Participants With Food Insecurity | Food insecurity is defined as > 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module | ITT | Posted | Count of Participants | Participants | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Secondary | Diabetes Distress Scale | Diabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better | ITT | Posted | Mean | Standard Deviation | units on a scale | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Hemoglobin A1c | This will be measured using a fasting blood draw at baseline, 12 and 24 weeks | ITT | Posted | Mean | Standard Deviation | % of hemoglobin | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | LDL Cholesterol | A fasting blood draw will be used to measure: LDL Cholesterol | ITT | Posted | Mean | Standard Deviation | mg/dl | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Body Mass Index | Body Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale. Height measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness. | ITT | Posted | Mean | Standard Deviation | kg/m^2 | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Systolic Blood Pressure | Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest. | ITT | Posted | Mean | Standard Deviation | mm hg | Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer |
|
|
|
| Other Pre-specified | Diastolic Blood Pressure | Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest. | ITT | Posted | Mean | Standard Deviation | mm hg | Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer |
|
|
|
| Other Pre-specified | Change From Baseline in Medication Adherence | Change from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better | ITT | Posted | Mean | Standard Deviation | units on a scale | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Number of Participants With Cost Related Medication Under-Use | Cost Related Medication Under-use (Defined as > 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey) | ITT | Posted | Count of Participants | Participants | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Number of Participants With Food and Medication Trade-offs | Prevalence of food and medication trade-offs between groups | ITT | Posted | Count of Participants | Participants | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Depressive Symptoms (Assessed Using the PHQ-8 Scale) | Patient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms | ITT | Posted | Mean | Standard Deviation | units on a scale | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Change From Baseline in Cognitive Burden (Assessed Using Times on the Stroop Task) | This outcome was planned to be measured but not measured owing to technical difficulties in assessment | This outcome was planned to be measured but not measured owing to technical difficulties in assessment | Posted | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
| Other Pre-specified | Number of Participants With Self-reported Hypoglycemia | Report of hypoglycemia requiring assistance in last 3 months | ITT | Posted | Count of Participants | Participants | Measured at end of On-Meals Period and end of Off-Meals Period for each participant |
|
|
|
| Other Pre-specified | Triglycerides | A fasting blood draw will be used to measure: Triglycerides | ITT | Posted | Median | Inter-Quartile Range | mg/dl | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
|
|
|
| Other Pre-specified | HDL Cholesterol | A fasting blood draw will be used to measure: HDL Cholesterol | ITT | Posted | Mean | Standard Deviation | mg/dl | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
|
|
|
| Other Pre-specified | Total Cholesterol | A fasting blood draw will be used to measure: Total Cholesterol | ITT | Posted | Mean | Standard Deviation | mg/dl | Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw |
|
|
|
| 0 |
| 42 |
| 0 |
| 42 |
| 0 |
| 42 |
| EG001 | Usual Care + Choose Myplate (Delayed) | Participants will receive usual diabetes care and a Choose MyPlate healthy eating brochure for 12 weeks. Usual Care + Choose MyPlate: Patients will receive usual diabetes care + a Choose MyPlate healthy eating brochure They will then receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet | 0 | 42 | 0 | 42 | 0 | 42 |
Not provided
Not provided